ВАН НОРРЕН Класке (NL),ВАН ХЕЛВОРТ Адрианус Ламбертус Берхолдус (NL),ФАБЕР Джойс (NL),ХАГЕМАН Роберт Йохан Йосеф (NL),ВОС Арьян Паул (NL)
申请号：
RU2013151169/13
公开号：
RU2013151169A
申请日:
2013.11.18
申请国别(地区):
RU
年份:
2015
代理人:
摘要：
1. The use of a combination of whey protein, leucine and at least ω-3 polyunsaturated fatty acid selected from the group: eicosapentaenoic acid, docosahexaenoic acid, eicosatetraenoic acid and docosapentaenoic acid, to improve muscle function in a mammal. The use of a nutritional composition containing the combination according to claim 1, which includes: (a) at least 18 en.% Protein material, wherein said protein material contains whey protein； (b) at least 12 wt.% Leucine to the total protein material； and (c) a lipid fraction containing at least ω-3 polyunsaturated fatty acid selected from the group of eicosapentaenoic acid, docosahexaenoic acid, eicosatetraenoic acid and docosapentaenoic acid, to improve muscle function in a mammal. 3. The use of the combination according to claim 1 or the nutritional composition according to claim 2, where muscle function is a function of skeletal muscle. The use according to claim 3, wherein the improvement of skeletal muscle function includes attenuation of loss of muscle function depending on muscle mass, in particular, includes correction of maximum muscle strength, maximum contraction rate or maximum relaxation rate of skeletal muscle. The use according to claim 3, where the improvement of skeletal muscle function includes attenuation of loss of muscle function independent of muscle mass, in particular, includes correction of the maximum strength adjusted for muscle mass, the maximum speed of contraction corrected for muscle mass, or the maximum relaxation rate, adjusted for muscle mass. 6. The use according to claim 1 or 2,1. Применение комбинации сывороточного белка, лейцина и по меньшей мере ω-3 полиненасыщенной жирной кислоты, выбранной из группы: эйкозапентаеновой кислоты, докозагексаеновой кислоты, эйкозатетраеновой кислоты и докозапентаеновой кислоты, для улучшения мышечной функции у млекопитающего.2. Применение питательной композиции, содержащей комбинацию по п.1, которая включает:(a) по меньшей мере 18 эн.% белков
